Simplify Logo

Full-Time

Quality Engineer

Confirmed live in the last 24 hours

Tempus

Tempus

1,001-5,000 employees

AI-driven healthcare data analysis platform

AI & Machine Learning
Biotechnology
Healthcare

Junior, Mid

Chicago, IL, USA

Position is onsite.

Category
QA & Testing
Quality Assurance
Requirements
  • 2+ years of experience in the Medical Device/Pharmaceutical regulated industry.
  • BS degree in Engineering field such as Biomedical, Bioengineering or Chemical Engineering
  • Experience with applicable FDA, European and other relevant clinical/regulatory requirements, international standards, including ISO 9001, ISO 13485, ISO 14971, EU IVDR/MDR and 21 CFR 820, etc.
  • Experience working in a fast-paced project core-team environment
  • Excellent oral and written communication skills and can communicate at multiple levels in the organization
  • Proficient in Microsoft Office (Word, PowerPoint, Excel, etc.)
  • Proficient in eQMS systems (Jama, ETQ, Pilgrim SmartSolve, etc.)
  • Analytical skills and ability to understand technical data
Responsibilities
  • Responsible for implementation of quality assurance principles and practices for design and maintenance of Tempus’ assay products and manufacturing processes
  • Responsible for product risk management activities during initial product realization and during product changes, pre- and post-launch
  • Responsible for quality assurance review for correctness and completeness of Tempus documents and records
  • Participate in the planning and development of project DHF and DMR documentation
  • Participate in internal and external quality system audits as required
  • Participate in root cause investigations as quality events/incidents arise
  • Participate in design transfer and process validation activities
  • Coordinate identification and monitoring of quality metrics and indicators
  • Coordinate change management process, ensuring change impact and action items are appropriately evaluated, tested and documented
  • Support other duties as assigned

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in the healthcare sector. The company offers a platform that analyzes medical data, helping physicians make better treatment decisions by providing insights from medical images and identifying care gaps. For pharmaceutical and biotech companies, Tempus aids in drug development by discovering new targets and assessing treatment effectiveness. Patients benefit from personalized therapy options identified through the platform. Tempus conducts significant research, particularly in cancer, and has developed tools like a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. The company generates revenue by charging healthcare providers and companies for access to its platform and insights.

Company Stage

Series G

Total Funding

$1.3B

Headquarters

Chicago, Illinois

Founded

2015

Growth & Insights
Headcount

6 month growth

4%

1 year growth

13%

2 year growth

35%
Simplify Jobs

Simplify's Take

What believers are saying

  • Tempus's IPO and significant revenue generation indicate strong financial health and growth potential.
  • Collaborations with industry giants like SoftBank and United Therapeutics can lead to groundbreaking advancements and increased market share.
  • The company's focus on personalized therapy and AI-driven insights can significantly improve patient outcomes, making it a rewarding place to work for those passionate about healthcare innovation.

What critics are saying

  • The lawsuit from Guardant Health over patent infringement could result in financial and reputational damage.
  • Operating in a highly competitive market with peers like Foundation Medicine and Guardant Health requires continuous innovation to maintain a competitive edge.

What makes Tempus unique

  • Tempus leverages AI to provide actionable insights from medical data, setting it apart from competitors who may not integrate AI as deeply into their platforms.
  • Their focus on personalized therapy options and extensive cancer research, including a pan-cancer organoid platform and liquid biopsy assay, distinguishes them in the healthcare tech space.
  • Tempus's collaboration with major firms like SoftBank and United Therapeutics highlights its strong industry partnerships and credibility.

Help us improve and share your feedback! Did you find this helpful?